## JBL: Jabil Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.8% in mid entry zone (3.0-6.0%), top quartile (89th pct) cross-sectional ranking. Short-term MRS_5 (2.1%) confirms momentum alignment. Momentum building (+0.8% 5-day). Outperforming sector by 3.4%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($214.39)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Jabil opens Advanced Catheter Development Lab at Florida HQ**
- Source: Medical Design & Outsourcing | 20251208T210818 | Bullish | Relevance: 99%
-  Jabil has launched its new Advanced Catheter Development Lab at its St. Petersburg, Florida headquarters. This facility, part of the Jabil Innovation Center, focuses on advancing minimally invasive medical device technology, particularly for catheters, through engineering, prototyping, and new product introduction. Jabil will collaborate with the University of Florida and University of South Florida faculty to integrate real-world operating room experiences into next-generation medtech development.

**2. BofA Securities raises Jabil stock price target to $262 on AI strength**
- Source: Investing.com | 20251210T100852 | Bullish | Relevance: 99%
-  BofA Securities has increased its price target for Jabil (NYSE:JBL) to $262.00 from $255.00, maintaining a Buy rating amidst strong anticipated AI revenues for the company's fiscal first quarter 2026 earnings. Jabil is also reportedly acquiring Hanley Energy Group for $725 million and expanding its operations and partnerships in AI-driven cybersecurity and battery energy storage. Despite capacity limitations due to retrofitting factories for liquid cooling, BofA projects a potential upside to Jabil's fiscal 2026 earnings per share guidance.

**3. Jabil Prepares For Key Earnings During AI, Infrastructure Shifts**
- Source: Benzinga | 20251210T180050 | Somewhat-Bullish | Relevance: 99%
-  Jabil Inc. (NYSE: JBL) is facing downward pressure on its stock ahead of its Q1 fiscal year 2026 earnings report, with investors focused on AI demand, new capacity projects, and a recent power-infrastructure deal. BofA Securities reiterated a Buy rating, raising the price target from $255 to $262, anticipating continued strength in AI-related revenue and improved fiscal performance in 2027. The company's acquisition of Hanley Energy and upcoming facility operations are expected to boost future revenue and margins.

**4. Jabil Gets A Price Target Hike As Growth Plans Take Shape**
- Source: Finimize | 20251210T161106 | Bullish | Relevance: 98%
- BofA Securities raised its price target for Jabil to $262, maintaining a buy rating, despite the stock dipping slightly this week. This confidence is attributed to Jabil's long-term growth strategy, which includes new factory expansions in North Carolina and Croatia, strengthening its position in AI-driven projects and the GLP-1 drug market, as well as a potential acquisition. These moves are expected to boost revenue and margins by 2027, showcasing how manufacturing is adapting to technological innovation and strategic acquisitions to secure future demand.

**5. Has Jabilâ€™s 469.9% Five Year Surge Left Any Value on the Table in 2025?**
- Source: Simply Wall Street | 20251209T000815 | Somewhat-Bullish | Relevance: 98%
- Jabil (NYSE: JBL) has seen significant growth, up 469.9% over five years, leading investors to question its current valuation at around $225. A Discounted Cash Flow analysis suggests it's undervalued by 12.8% at $258.47 per share, while its Price-to-Earnings ratio of 36.7x, compared to a calculated 'Fair Ratio' of 31.2x, indicates it might be somewhat overvalued based on its fundamentals. The article suggests using "Narratives" for a personalized valuation, incorporating individual beliefs about the company's future performance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | B of A Securiti | $262 | $255 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | B of A Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.00M) |
| Sells | 50 ($12.50M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (-0.1%)
- Blackrock Inc.: 9.0% (+2.1%)
- Texas Yale Capital C: 6.0% (-0.1%)
- State Street Corpora: 4.9% (+0.7%)
- Wellington Managemen: 4.1% (-30.7%)

### Key Risks

1. Heavy insider selling: $13M sold (50 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.91 indicates undervaluation relative to growth. Quality metrics strong (ROE 40%). Insider selling cluster ($12.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $24.7B |
| Beta | 1.26 |
| 52W Range | $108.66 - $237.14 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.91 |
| Forward P/E | 17.8 |
| Current P/E | 20.7 |
| YoY Growth | 16.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.8% over 5 days). Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 89th percentile. MRS_5 at 2.1% confirms short-term momentum alignment. Outperforming sector by 3.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.00), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.81% (CS: 89) | Strong |
| RSI_14 | 69.1 | Neutral |
| MACD Histogram | 3.00 | Bullish |
| vs SMA20 | 1.099x | Above |
| vs SMA50 | 1.098x | Above |
| vs SMA200 | 1.215x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $229.97
- **Stop Loss:** $214.39 (6.8% risk)
- **Target:** $253.34 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $17,707.69
- **Portfolio %:** 17.71%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2025-12-17 (Est: $2.72)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.95 | $3.29 | +11.7% |
| 2025Q2 | $2.32 | $2.55 | +9.8% |
| 2025Q1 | $1.83 | $1.94 | +6.2% |
| 2024Q4 | $1.88 | $2.00 | +6.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*